Feasibility of using pemetrexed as a salvage regimen in heavily pre-treated patients with ovarian cancer: A retrospective review

被引：1
|
作者：
Dottino, Peter [1 ]
Dashkoff, Matthew [1 ]
Beddoe, Ann Marie [1 ]
机构：
[1] Icahn Sch Med, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA
来源：
INDIAN JOURNAL OF CANCER | 2020年 / 57卷 / 04期
关键词：
SURVIVAL;
D O I：
10.4103/ijc.IJC_284_19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：491 / 493
页数：3
相关论文
共 50 条
  • [41] Lenolidamide (Revlimid), in combination with cyclophosphamide and dexamethasone (CRD) is an effective regimen for heavily pre-treated myeloma patients.
    Morgan, Gareth J.
    Schey, Stephen
    Wu, Ping
    Srikanth, M.
    Phekoo, Karen J.
    Jenner, Matthew W.
    Dines, Sharon
    Saso, Radovan
    Davies, Faith E.
    BLOOD, 2006, 108 (11) : 1015A - 1015A
  • [42] Bevacizumab in Heavily Pre-treated and Platinum Resistant Ovarian Cancer: A Retrospective Study of the North-Eastern German Society of Gynaecologic Oncology (NOGGO) Ovarian Cancer Study Group
    Pietzner, Klaus
    Richter, Rolf
    Chekerov, Radoslav
    Erol, Edibe
    Oskay-Oezcelik, Guelten
    Lichtenegger, Werner
    Sehouli, Jalid
    ANTICANCER RESEARCH, 2011, 31 (08) : 2679 - 2682
  • [43] Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma
    Papanikolaou, Xenofon
    Szymonifka, Jackie
    Rosenthal, Adam
    Heuck, Christoph J.
    Mitchell, Alan
    Johann, Donald, Jr.
    Keller, Jason
    Waheed, Sarah
    Usmani, Saad Z.
    Van Rhee, Frits
    Bailey, Clyde
    Petty, Nathan
    Hoering, Antje
    Crowley, John
    Barlogie, Bart
    HAEMATOLOGICA, 2013, 98 (07) : 1147 - 1153
  • [44] Feasibility of proton beam therapy as a rescue therapy in heavily pre-treated retinoblastoma eyes
    Biewald, E.
    Kiefer, T.
    Dirk, G.
    Sabrina, S.
    Sophia, G.
    Joerg, W.
    Beate, T.
    Petra, K.
    Stefan, S.
    Saskia, T.
    Nikolaos, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1067 - 1067
  • [45] Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes
    Biewald, Eva
    Kiefer, Tobias
    Geismar, Dirk
    Schlueter, Sabrina
    Manthey, Anke
    Westekemper, Henrike
    Wulff, Joerg
    Timmermann, Beate
    Ketteler, Petra
    Schoenberger, Stefan
    Metz, Klaus A.
    Ting, Saskia
    Goricke, Sophia
    Bechrakis, Nikolaos E.
    Bornfeld, Norbert
    CANCERS, 2021, 13 (08)
  • [46] "Ethinylestradiol" is beneficial for postmenopausal advanced breast cancer patients heavily pre-treated with endocrine agents
    Iwase, H.
    Yamamoto, Y.
    Murakami, K-I
    Yamamoto-Ibusuki, M.
    Tomita, S.
    Omoto, Y.
    CANCER RESEARCH, 2012, 72
  • [47] Effective Panitumumab Treatment in Patients with Heavily Pre-treated Metastatic Colorectal Cancer: A Case Series
    Tzovaras, Alexandros A.
    Karagiannis, Athanassios
    Margari, Charalambia
    Barla, Georgia
    Ardavanis, Alexandros
    ANTICANCER RESEARCH, 2011, 31 (03) : 1033 - 1037
  • [48] Eribulin monotherapy in heavily pre-treated patients with advanced breast cancer: "Real world" experience
    Sanganalmath, P.
    Purohit, K.
    Winter, M.
    Horsman, J.
    Ramakrishnan, S.
    Hatton, M.
    Lee, C.
    Dunn, K.
    Din, O.
    Coleman, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S181 - S182
  • [49] Capecitabine for Salvage Treatment of Patients with Heavily Pre-treated Human Papillomavirus-Associated Oropharynx Cancer (HPV-OPC) with Distant Metastases
    Fazer, C.
    Chintakuntlawar, A. V.
    Price, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1183 - 1183
  • [50] UNDERSTANDING THE UTILITY VALUE OF PATIENTS WITH HEAVILY PRE-TREATED MULTIPLE MYELOMA
    Hadi, M.
    Swinburn, P.
    de Freitas, H. M.
    Ito, T.
    VALUE IN HEALTH, 2016, 19 (07) : A389 - A389
12345